Figures computed from official regulatory filings — .
Statistical track record
Free accountWin rates, median returns and the proven-insider analysis come with a free account.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Outset Medical, Inc.Listing on record | Buy | $806K | conv 63Unusual sizeFirst in 12mo | SEC | |
Outset Medical, Inc.Listing on record | Buy | $64.2K | conv 29 | SEC | |
Outset Medical, Inc.Listing on record | Other | $1.6M | SEC | ||
Outset Medical, Inc.Listing on record | Other | $484.5K | SEC | ||
Outset Medical, Inc.Listing on record | Other | $988K | SEC | ||
Aclaris Therapeutics, Inc.Listing on record | Sell | $1.4M | SEC | ||
Adverum Biotechnologies, Inc.Listing unverified | Sell | $2.2M | SEC | ||
Adverum Biotechnologies, Inc.Listing unverified | Sell | $1.3M | SEC | ||
Adverum Biotechnologies, Inc.Listing unverified | Sell | $929.6K | SEC | ||
Adverum Biotechnologies, Inc.Listing unverified | Sell | $218.2K | SEC | ||
ASTROTECH CorpListing on record | Sell | $53.4K | SEC | ||
ASTROTECH CorpListing on record | Sell | $1.6M | SEC | ||
AN2 Therapeutics, Inc.Listing on record | Sell | $218K | SEC | ||
AN2 Therapeutics, Inc.Listing on record | Sell | $7.2K | SEC | ||
AN2 Therapeutics, Inc.Listing on record | Sell | $429.3K | SEC | ||
AN2 Therapeutics, Inc.Listing on record | Sell | $116K | SEC | ||
AN2 Therapeutics, Inc.Listing on record | Sell | $2.3M | SEC | ||
Adverum Biotechnologies, Inc.Listing unverified | Buy | $102.9K | conv 26 | SEC | |
Adverum Biotechnologies, Inc.Listing unverified | Buy | $86.1K | conv 24 | SEC | |
Adverum Biotechnologies, Inc.Listing unverified | Buy | $149K | conv 31 | SEC | |
Adverum Biotechnologies, Inc.Listing unverified | Buy | $900K | conv 51Unusual size | SEC | |
Adverum Biotechnologies, Inc.Listing unverified | Buy | $85.7K | conv 20 | SEC | |
Adverum Biotechnologies, Inc.Listing unverified | Buy | $61.4K | conv 20 | SEC | |
Adverum Biotechnologies, Inc.Listing unverified | Buy | $102.9K | conv 26 | SEC | |
Adverum Biotechnologies, Inc.Listing unverified | Buy | $86.1K | conv 26 | SEC |